CAR-T cells are specialized immune cells genetically modified to recognize and attack cancer cells. Researchers at Nagoya ...

Given the probability of trial success and current valuation, we rate the ATYR stock 'Hold' as risk and reward appear ...

Back-to-back studies map complementary hunger and satiety pathways, offering clues to refine weight-loss drugs.

Dr. Mabel Mardones educates patients on breast cancer subtypes, as well as treatment options for those with ER-positive, HER2 ...

Amplifye, a startup led by former Amyris CEO John Melo, has launched its first product: an enzyme claimed to optimize protein ...

A drug used for high blood pressure, known as rilmenidine, may also be effective in slowing the aging process, even in older ...

"Omega-3 fatty acids have been known for their cardioprotective effects and they have broad anti-inflammatory properties, ...

Increased activity in a specific biological pathway may explain why many patients with a deadly form of skin cancer do not ...

CAR-T cells are specialized immune cells genetically modified to recognize and attack cancer cells. Researchers at Nagoya ...

Researchers have found a genetic mutation that can worsen iron deficiency and anaemia in patients with Crohn’s disease. Crohn ...

KØBENHAVN, DK / ACCESS Newswire / June 10, 2025 / FluoGuide A/S (STO:FLUO) - Copenhagen, Denmark - FluoGuide A/S ("FluoGuide" or the "Company"), a clinical-stage biotech company focused on precision ...

Increased activity in a specific biological pathway may explain why many patients with a deadly form of skin cancer do not ...